News and Press Releases
Pharma services boom in China as CPHI & PMEC China posts record attendance
Domestic and international markets in Asia surging as CPHI & PMEC China welcomes a staggering 93,000 attendees 8 August 2024 – Shanghai, China and Amsterdam, the Netherlands – The pharma...
Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Delivery, Drug Discovery, Manufacturing and Packing
Posted: August 8, 2024
Newcells Biotech launches high-content and high-throughput imaging suite to advance pre-clinical drug development programmes
Investment in state-of-the-art imaging suite to accelerate data generation with physiologically-relevant in vitro models for deeper insights on drug effects in vivo Launch of advanced lung FMT assay provides extensive...
Category: Drug Discovery
Posted: August 8, 2024
Newcells Biotech, The Biophere, Drayman's Way, newcastle Helix, Newcastle-upon-Tyne, NE4 5BX
MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene therapy viral vector analytics and purification
Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral vectors in cell and gene therapy Rebrand follows Series...
Category: BioManufacturing, Biotechnology
Posted: August 7, 2024
Pharma manufacturing giant Asymchem opens European HQ at Discovery Park
Sandwich, Kent, UK / 6th August 2024 / Asymchem Laboratories (Tianjin) Co., Ltd. has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent,...
Category: Manufacturing and Packing, Pharmaceutical
Posted: August 6, 2024
Asymchem Laboratories (Tianjin) Co., Ltd No. 6 Dongting 3rd Avenue, TEDA Tianjin, 300457, P.R. China
AAPS Elevates Eight Members to Fellow Status
Fellows Program Recognizes Scientific Impact, Leadership, and Service Arlington, VA—AAPS is pleased to announce that eight members have been selected for elevation to Fellow status in recognition of their professional...
Category: Other, Pharmaceutical
Posted: August 1, 2024
2107 Wilson Blvd #200 Arlington, VA 22201
AAPS Announces 2024 Awards Recipients
Awards Program Recognizes Scientific Impact, Leadership, and Service Arlington, VA—AAPS is proud to announce the recipients of the 2024 Awards Program. AAPS Awards celebrate scientists who are role models in...
Category: Other, Pharmaceutical
Posted: August 1, 2024
2107 Wilson Blvd #200 Arlington, VA 22201
Major distribution centre opens to support health services in North West England
18 July 2024 – Nottingham, UK – A new NHS Supply Chain regional distribution centre that will support 115 NHS Trusts is now fully operational, providing a more resilient and...
Category: Logistics, Manufacturing and Packing
Posted: July 31, 2024
SSI Strategy and Metalmind Partner for Enterprise AI Solutions
23 July 2024 , New Jersey US, Kista, Sweden, – SSI Strategy LLC, a global leader in strategic consulting for life sciences, is pleased to announce a partnership with MPS...
Category: Biotechnology
Posted: July 30, 2024
COREX Logistics Appoints New CEO to Expand Global Growth
Clinical trial and pharmaceutical logistics specialists COREX Logistics have announced the appointment of Steve Healy as its new CEO of the organisation. Healy, COREX Logistics’ former Vice President of Business...
Category: Clinical Trials, Logistics, Other
Posted: July 30, 2024
Suite 40, The Guinness Enterprise Centre, Taylors Lane, Dublin 8, Ireland
AOTI announces US FDA 510(k) Clearance of NEXATM NPWT System for use in the home care setting
Extension to indications for use follows submission of results from a human factors study evaluating the safe and effective use of the device in the home care setting AOTI, INC.,...
Category:
Posted: July 29, 2024
3512 Seagate Way Suite 100 Oceanside, CA 92056, US
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced EGFR-mutated non-small cell lung cancer (NSCLC) after failure of prior therapy
Patients with EGFR ex19del or EGFR L858R mutations, the most common EGFR mutations in NSCLC, currently face a poor prognosis and limited treatment options after disease progression on osimertinib1,2,3,4 ...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 26, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Johnson & Johnson Receives Positive CHMP Opinion for Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive PAH portfolio has the potential to cover all guideline-recommended treatment...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 26, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
Deuterium Depletion Is the Key to Getting a Breakthrough in Cancer Therapy
Two review papers consolidate 30 years of research BUDAPEST, Hungary, July 25, 2024 / Biotech Newswire / -- HYD LLC for Cancer Research and Drug Development (HYD or the Company)...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: July 25, 2024
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80% 25 July 2024, New York, US – Medidata, a Dassault Systèmes brand and leading provider of clinical trial...
Category:
Posted: July 25, 2024
Epitopea Announces Leadership Transition and New Appointments
Alan C. Rigby Joins as CEO, Jon Moore Transitions to CSO 25 July 2024, Cambridge, UK and Montreal, Canada – Epitopea, a transatlantic RNA immunotherapeutics company and global leader exploiting...
Category:
Posted: July 25, 2024
Salisbury House, Station Road, Cambridge, Cambridgeshire, United Kingdom, CB1 2LA
